NashBio Email Format
Biotechnology ResearchTennessee, United States11-50 Employees
NashBio is a biotechnology research company based in Nashville, Tennessee, operating as a for-profit subsidiary of Vanderbilt University Medical Center, and it was launched in 2018. It aims to make complex healthcare data usable by leveraging real-world clinical, genomic, and imaging data alongside bioinformatics tools to support the discovery and development of therapeutics and diagnostics. The company emphasizes deep, high-quality longitudinal datasets that are demographically diverse and clinically relevant, which are integrated and curated to facilitate customer use, and it serves clients in pharma, biotech, diagnostics, medical devices and other life sciences domains. In 2023, NashBio launched the Alliance for Genomic Discovery (AGD) in collaboration with Illumina and eight pharmaceutical companies to assemble a large collection of whole genome sequence data linked to de-identified medical records for drug discovery and development. NashBio is located at 2525 West End Avenue, Suite 930, Nashville, TN 37203, United States, and employs between 11 and 50 people.